Professional Documents
Culture Documents
Ch 17 select problem solutions
Ch 17 select problem solutions
Before After
Stock Stock
Dividend Dividend1
1
Effect of the stock dividend is reflected in the May 31, 2023 weighted
average number of shares for comparative purposes on the 2024
financial statements.
b. LORETTA CORPORATION
Comparative Income Statement
For the Years Ended May 31,
2024 2023
2024 2023
Income from continuing operations $640,000 $960,000
Preferred dividend (1) (100,000) (100,000)
540,000 860,000
Weighted average number of shares 1,800,000 1,650,000
2024
Net income – Preferred dividend $ 460,000
Weighted average number of shares 1,800,000
Net income per share $ 0.26
4. IFRS requires the disclosure of basic and diluted earnings per share
be made on the face of the income statement. Companies that report a
discontinued operation must present per share amounts for this line item
either on the face of the income statement or in the notes to the financial
statements. ASPE does not have any requirements for calculation or
presentation of EPS.
Copyright © 2022 John Wiley & Sons Canada, Ltd. Unauthorized copying, distribution, or transmission of this page is
strictly prohibited.
P8
The calculation of Camden Pharmaceutical Industries’ basic and diluted
earnings per share for the fiscal year ended June 30, 2023, are shown below.
a.
Basic Earnings Per Share Income Shares EPS
Net Income $1,500,000
Dividends on preferred
(25,000 X $4.25) (106,250)
Basic EPS $1,393,750 1,000,000 $1.39
Individual earnings per share calculations are done for each potentially
dilutive security to determine if the security is in fact dilutive when
compared to basic earnings per share of $1.39. Only dilutive securities
will be used in the calculation of diluted earnings per share. Each will
be used in sequence, from most dilutive to least dilutive to arrive at the
most diluted earnings per share result. In the ranking of securities,
options will be used first if they are in the money (exercise price of $15
is below the average market price $20).
For Options:
Use treasury stock method to determine incremental
shares outstanding.
Proceeds from exercise of options
(100,000 X $15) $1,500,000
Copyright © 2022 John Wiley & Sons Canada, Ltd. Unauthorized copying, distribution, or transmission of this page is
strictly prohibited.
$5,000,000 / $1,000 = 5,000 bonds
Increase in diluted earnings per share denominator:
5,000
X 50
250,000
P9
The calculations of Twilight Limited’s basic and diluted earnings per share
for the 2023 fiscal year are shown below.
a.
Basic Earnings Per Share Income Shares EPS
Net Income $2,500,000
Dividends on preferred
(600,000 x $.68) (408,000)
Basic EPS $2,092,000 3,000,000 $0.70
b.
Step 1: Determine, for each dilutive security, the incremental per share effect
if the security is exercised or converted.
Individual earnings per share calculations are done for each potentially
dilutive security to determine if the securities are in fact dilutive when
compared to basic earnings per share of $0.70. Only dilutive securities
will be used in the calculation of diluted earnings per share. Each will
be used in sequence, from most dilutive to least dilutive, to arrive at the
most diluted earnings per share result. In the ranking of securities,
options will be used first if they are in the money (exercise price of $8 is
below the average market price of $14).
For Options:
Use treasury stock method to determine incremental
shares outstanding.
Proceeds from exercise of options
(100,000 X $8) $800,000
Copyright © 2022 John Wiley & Sons Canada, Ltd. Unauthorized copying, distribution, or transmission of this page is
strictly prohibited.
Shares issued upon exercise of options 100,000
Shares purchasable with proceeds
(Proceeds ÷ Average market price)
($800,000 ÷ $14) 57,143
Incremental shares outstanding 42,857
Copyright © 2022 John Wiley & Sons Canada, Ltd. Unauthorized copying, distribution, or transmission of this page is
strictly prohibited.
Dividends avoided from conversion $0.68 X 600,000 shares =
$408,000 divided by 600,000 additional common shares (one to one
ratio) = $0.68 < $0.70
Step 2: Rank the results from the lowest earnings effect per share to the
largest; that is, rank the results from the most dilutive to least dilutive.
Step 3: Beginning with the basic earnings per share based on the
weighted average number of common shares outstanding, recalculate
the earnings per share by adding the most dilutive per share effect from
the first step. If the result from this recalculation is less than EPS in the
prior step, go to the next most dilutive per share effect and recalculate
the earnings per share until a security maintains or increases the EPS,
and is antidilutive.
a.
Basic Earnings Per Share Income Shares EPS
Net Income $2,300,000
Dividends on preferred
Copyright © 2022 John Wiley & Sons Canada, Ltd. Unauthorized copying, distribution, or transmission of this page is
strictly prohibited.
(4,000,000 X 6%) (240,000)
Basic EPS $ 2,060,000 600,000 $3.43
a. Individual earnings per share calculations are done for each potentially
dilutive security to determine if the security is in fact dilutive when
compared to basic earnings per share of $3.43. Only dilutive securities
will be used in the calculation of diluted earnings per share. Each will
be used in sequence, from most dilutive to least dilutive, to arrive at the
most diluted earnings per share result. In the ranking of securities,
options will be used first if they are in the money (exercise price of $20
is below the average market price of $25).
For Options:
Use treasury stock method to determine incremental
shares outstanding.
Proceeds from exercise of options
(75,000 X $20) $1,500,000
Copyright © 2022 John Wiley & Sons Canada, Ltd. Unauthorized copying, distribution, or transmission of this page is
strictly prohibited.
For 6% convertible preferred shares:
Dividends avoided from conversion 6% X $4,000,000 = $240,000
divided by ($4,000,000 / $100 par) or 40,000 preferred shares X 3
(one to three ratio) = 120,000 additional common shares = $2.00 <
$3.43 — Ranked least dilutive.
Copyright © 2022 John Wiley & Sons Canada, Ltd. Unauthorized copying, distribution, or transmission of this page is
strictly prohibited.